Aaron Damien Barzey MSc

Aaron Damien Barzey was the Global Labelling lead for the orphan drug ‘ofatumumab’. He was responsible for the company's core datasheets, labelling strategy, and EU labelling negations and oversaw the product launch in emerging markets. My major accomplishment was leading the launch of Arzerra for the treatment of chronic lymphatic leukaemia across the EU, Australia and other countries. In 2015 Aaron started his own regulatory consultancy, ADB Medical, providing ad-hoc support or project-specific guidance to various companies. In 2016 Aaron was chosen as the pharmaceutical industry SME to discuss the possible impact of Brexit on the pharmaceutical industry, which included debating with Nigel Farage live on national television and discussing further life on UK TV with Piers Morgan and Susanna Reid.